Canada Semaglutide Go-ahead: Which Way Will The Wind Blow For Dr Reddy’s?

 
• By Anju Ghangurde
  
Maple leaves
Dr Reddy's awaits feedback from the Canadian regulator for semaglutide (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Focus On Asia

More from Scrip